Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Short-Term Debt issuances (2019 - 2024)

AdaptHealth has reported Short-Term Debt issuances over the past 5 years, most recently at $178.5 million for Q3 2024.

  • Quarterly results put Short-Term Debt issuances at $178.5 million for Q3 2024, changed N/A from a year ago — trailing twelve months through Jun 2025 was $178.5 million (up 42.78% YoY), and the annual figure for FY2024 was $253.5 million, up 406.95%.
  • Short-Term Debt issuances for Q3 2024 was $178.5 million at AdaptHealth, up from $75.0 million in the prior quarter.
  • Over the last five years, Short-Term Debt issuances for AHCO hit a ceiling of $795.0 million in Q1 2021 and a floor of $50.0 million in Q1 2023.
  • Median Short-Term Debt issuances over the past 4 years was $95.0 million (2021), compared with a mean of $228.9 million.
  • Peak annual rise in Short-Term Debt issuances hit 1035.71% in 2021, while the deepest fall reached 79.63% in 2021.
  • AdaptHealth's Short-Term Debt issuances stood at $55.0 million in 2020, then surged by 72.73% to $95.0 million in 2021, then crashed by 47.37% to $50.0 million in 2023, then skyrocketed by 256.95% to $178.5 million in 2024.
  • The last three reported values for Short-Term Debt issuances were $178.5 million (Q3 2024), $75.0 million (Q1 2024), and $50.0 million (Q1 2023) per Business Quant data.